Corvus Pharmaceuticals Inc (CRVS) EPS is poised to hit -0.11 next quarter: How Investors Can Make It Count the Most?
As on Wednesday, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) got off with the flyer as it spiked 9.38% to $7.35, before settling in for the price